NCT00192712View on ClinicalTrials.gov

Irinotecan, Gemcitabine and Radiation Therapy for Pancreatic Cancer

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 30, 2002

Study Completion Date

September 30, 2010

Conditions
Pancreatic Cancer
Interventions
DRUG

irinotecan, gemcitabine

Trial Locations (1)

31096

Department of Oncology, Rambam Medical Center, Haifa

All Listed Sponsors
lead

Rambam Health Care Campus

OTHER

NCT00192712 - Irinotecan, Gemcitabine and Radiation Therapy for Pancreatic Cancer | Biotech Hunter | Biotech Hunter